Design and optimization of orally spleen tyrosine kinase (SYK) inhibitors for treatment of solid tumor.

Wang, Cheng

Design and optimization of orally spleen tyrosine kinase (SYK) inhibitors for treatment of solid tumor. [electronic resource] - Bioorganic chemistry 01 2020 - 103547 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1090-2120

10.1016/j.bioorg.2019.103547 doi


Administration, Oral
Antineoplastic Agents--administration & dosage
Cell Line, Tumor
Drug Design
Humans
Neoplasms--drug therapy
Protein Kinase Inhibitors--administration & dosage
Syk Kinase--antagonists & inhibitors